Cerebrovascular insulin receptors are defective in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Central response to insulin is suspected to be defective in Alzheimer’s disease. As most insulin is secreted in the bloodstream by the pancreas, its capacity to regulate brain functions must, at least partly, be mediated through the cerebral vasculature. However, how insulin interacts with the blood–brain barrier and whether alterations of this interaction could contribute to Alzheimer’s disease pathophysiology both remain poorly defined. Here, we show that human and murine cerebral insulin receptors (INSRs), particularly the long isoform INSRα-B, are concentrated in microvessels rather than in the parenchyma. Vascular concentrations of INSRα-B were lower in the parietal cortex of subjects diagnosed with Alzheimer’s disease, positively correlating with cognitive scores, leading to a shift towards a higher INSRα-A/B ratio, consistent with cerebrovascular insulin resistance in the Alzheimer’s disease brain. Vascular INSRα was inversely correlated with amyloid-β plaques and β-site APP cleaving enzyme 1, but positively correlated with insulin-degrading enzyme, neprilysin and P-glycoprotein. Using brain cerebral intracarotid perfusion, we found that the transport rate of insulin across the blood–brain barrier remained very low (<0.03 µl/g·s) and was not inhibited by an insulin receptor antagonist. However, intracarotid perfusion of insulin induced the phosphorylation of INSRβ that was restricted to microvessels. Such an activation of vascular insulin receptor was blunted in 3xTg-AD mice, suggesting that Alzheimer’s disease neuropathology induces insulin resistance at the level of the blood–brain barrier. Overall, the present data in post-mortem Alzheimer’s disease brains and an animal model of Alzheimer’s disease indicate that defects in the insulin receptor localized at the blood–brain barrier strongly contribute to brain insulin resistance in Alzheimer’s disease, in association with β-amyloid pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126 · cited 2×
“The 3xTg-AD mouse is a widely used model that progressively develops both Aβ deposits and neurofibrillary tangles (τ pathology) as well as cognitive deficits, due to the expression three mutant genes: β-amyloid precursors protein (APPswe), presenilin-1 (PS1MA146V) and tau (tauP301L) (Julien et al., 2010; Oddo et al.,…”
BackgroundVassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 3×
“On the other hand, INSRα-B was negatively correlated with BACE1, a β- secretase initiating the cleavage of APP and formation of APPβ-CTF and Aβ (Vassar et al., 1999), both found in higher concentrations in AD brain or microvessels (Bourassa et al., 2019b; Fukumoto et al., 2002; Li et al., 2004;…”
BackgroundInfluentialPhases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · cited 1×
“…of AD neuropathological changes (not, low, intermediate, or high) were determined using (A) Thal score assessing phases of Aβ plaque accumulation (Thal et al., 2002), (B) Braak score assessing neurofibrillary tangle pathology (Braak and Braak, 1991), and (C) CERAD score assessing neuritic…”
MethodMontine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894 · cited 1×
“logical diagnosis is based on the ABC scoring method found in the revised National Institute of Aging–Alzheimer’s Association (NIA-AA) guidelines for the neuropathological diagnosis of Alzheimer’s disease.(62) Four levels of Alzheimer’s disease neuro-”
MethodA molecular atlas of cell types and zonation in the brain vasculature
Vanlandewijck, M., He, L., Mäe, M. A., Andrae, J., Ando, K., Del Gaudio, F., Nahar, K., Lebouvier, T., Laviña, B., Gouveia, L., et al. (2018) · Nature · doi:10.1038/nature25739 · Cited by 1,892 · cited 4×
“However, more recent studies with RNA sequencing in mouse and human brain cells showed that INSR is largely expressed in endothelial and glial cells (Vanlandewijck et al., 2018; Yang et al., 2021; Zhang et al., 2020).”
BackgroundInfluentialTalbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871 · cited 7×
“Along with INSR, lower IGF-1R phosphorylation was observed following ex vivo stimulation with insulin in hippocampal sections from Alzheimer’s individuals.(21) Interestingly, insulin displays a greater affinity for INSRα-B homodimers compared to INSRα-A homodimers and hybrid receptors.”
BackgroundResultInfluentialSelf-citationSteen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Arnold, S. E., Arvanitakis, Z., Macauley-Rambach, S. L., Koenig, A. M., Wang, H.-Y., Ahima, R. S., Craft, S., Gandy, S., Buettner, C., Stoeckel, L. E., et al. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.185 · Cited by 1,597 · cited 3×
“Previous published data suggest that AD is associated with reduced activation of INSR and its downstream intracellular signaling (Arnold et al., 2018; Arvanitakis et al., 2020; Talbot et al., 2012).”
BackgroundNeuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336 · cited 3×
“mentia, mild cognitive impairment (MCI) or no cognitive impairment (NCI) (n = 20 for each group) at the time of death by a neurologist, blinded to all post-mortem data, as previously described.(56,58,59) In addition, current prescription medication usage in the last 2 weeks before each evaluation were available, such…”
MethodSelf-citation
Research works printed but not linked: 111
- Lewis, 2021, The discovery of insulin revisited: Lessons for the modern era, J Clin Invest, 131, 10.1172/JCI142239 · DOI
- Polyzos, 2021, Diabetes mellitus: 100 years since the discovery of insulin, Metabolism, 118, 154737, 10.1016/j.metabol.2021.154737 · DOI
- Moran, 2019, Diabetes therapies for dementia, Curr Neurol Neurosci Rep, 19, 58, 10.1007/s11910-019-0973-4 · DOI
- Frank, 1981, A direct in vitro demonstration of insulin binding to isolated brain microvessels, Diabetes, 30, 757, 10.2337/diab.30.9.757 · DOI · Paper page
- Haskell, 1985, Identification of the insulin receptor of cerebral microvessels, Am J Physiol Endocrinol Metab, 248, E115, 10.1152/ajpendo.1985.248.1.E115 · DOI
- Vicent, 2003, The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance, J Clin Invest, 111, 1373, 10.1172/JCI15211 · DOI · Paper page
- Belfiore, 2017, Insulin receptor isoforms in physiology and disease: An updated view, Endocr Rev, 38, 379, 10.1210/er.2017-00073 · DOI · Paper page
- Mosthaf, 1990, Functionally distinct insulin receptors generated by tissue-specific alternative splicing, Embo J, 9, 2409, 10.1002/j.1460-2075.1990.tb07416.x · DOI · Paper page
- Yamaguchi, 1993, Ligand-binding properties of the two isoforms of the human insulin receptor, Endocrinology, 132, 1132, 10.1210/endo.132.3.8440175 · doi:10.1210/endo.132.3.8440175
- Kellerer, 1992, Distinct alpha-subunit structures of human insulin receptor A and B variants determine differences in tyrosine kinase activities, Biochemistry, 31, 4588, 10.1021/bi00134a008 · DOI
- De Felice, 2013, Alzheimer’s disease and insulin resistance: Translating basic science into clinical applications, J Clin Invest, 123, 531, 10.1172/JCI64595 · DOI · Paper page
- Baglietto-Vargas, 2016, Diabetes and Alzheimer's disease crosstalk, Neurosci Biobehav Rev, 64, 272, 10.1016/j.neubiorev.2016.03.005 · DOI · Paper page
- de la Monte, 2019, The full spectrum of Alzheimer's disease is rooted in metabolic derangements that drive type 3 diabetes, Adv Exp Med Biol, 1128, 45, 10.1007/978-981-13-3540-2_4 · DOI · Paper page
- Stanley, 2016, The effects of peripheral and central high insulin on brain insulin signaling and amyloid-beta in young and old APP/PS1 mice, J Neurosci, 36, 11704, 10.1523/JNEUROSCI.2119-16.2016 · DOI · Paper page
- Arvanitakis, 2020, Brain insulin signaling, Alzheimer disease pathology, and cognitive function, Ann Neurol, 88, 513, 10.1002/ana.25826 · DOI · Paper page
- Vandal, 2014, Insulin reverses the high-fat diet-induced increase in brain Abeta and improves memory in an animal model of Alzheimer disease, Diabetes, 63, 4291, 10.2337/db14-0375 · DOI · Paper page
- Sanguinetti, 2019, Combined effect of fatty diet and cognitive decline on brain metabolism, food intake, body weight, and counteraction by intranasal insulin therapy in 3xTg mice, Front Cell Neurosci, 13, 188, 10.3389/fncel.2019.00188 · DOI
- Kellar, 2021, Intranasal insulin reduces white matter hyperintensity progression in association with improvements in cognition and CSF biomarker profiles in mild cognitive impairment and Alzheimer's disease, J Prev Alzheimers Dis, 8, 240
- Gwizdala, 2021, Placebo controlled phase II clinical trial: Safety and efficacy of combining intranasal insulin & acute exercise, Metab Brain Dis, 36, 1289, 10.1007/s11011-021-00727-2 · DOI
- Rosenbloom, 2021, A phase II, single-center, randomized, double-blind, placebo-controlled study of the safety and therapeutic efficacy of intranasal glulisine in amnestic mild cognitive impairment and probable mild Alzheimer's disease, Drugs Aging, 38, 407, 10.1007/s40266-021-00845-7 · DOI
- Hölscher, 2022, Protective properties of GLP-1 and associated peptide hormones in neurodegenerative disorders, Br J Pharmacol, 179, 695, 10.1111/bph.15508 · DOI · Paper page
- Cummings, 6 2022, Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease, Eur J Neurosci, 10.1111/ejn.15619 · DOI · Paper page
- Lourenco, 2015, Neuronal stress signaling and eIF2alpha phosphorylation as molecular links between Alzheimer's disease and diabetes, Prog Neurobiol, 129, 37, 10.1016/j.pneurobio.2015.03.003 · DOI
- Frazier, 2020, Molecular elevation of insulin receptor signaling improves memory recall in aged Fischer 344 rats, Aging Cell, 19, e13220, 10.1111/acel.13220 · DOI
- Moss, 1990, Location of phosphotyrosine-containing proteins by immunocytochemistry in the rat forebrain corresponds to the distribution of the insulin receptor, Proc Natl Acad Sci USA, 87, 4453, 10.1073/pnas.87.12.4453 · DOI · Paper page
- Unger, 1989, Distribution of insulin receptor-like immunoreactivity in the rat forebrain, Neuroscience, 31, 143, 10.1016/0306-4522(89)90036-5 · DOI · Paper page
- Doré, 1997, Distribution and levels of [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats, Neuroscience, 80, 1033, 10.1016/S0306-4522(97)00154-1 · DOI
- Kar, 1993, Quantitative autoradiographic localization of [125I]insulin-like growth factor I, [125I]insulin-like growth factor II, and [125I]insulin receptor binding sites in developing and adult rat brain, J Comp Neurol, 333, 375, 10.1002/cne.903330306 · DOI · Paper page
- Baskin, 1986, Quantitative autoradiographic evidence for insulin receptors in the choroid plexus of the rat brain, Diabetes, 35, 246, 10.2337/diab.35.2.246 · DOI · Paper page
- Zhang, 2020, Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human, Fluids Barriers CNS, 17, 47, 10.1186/s12987-020-00209-0 · DOI · Paper page
- Gali, 2019, Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice, Mol Cell Neurosci, 99, 103390, 10.1016/j.mcn.2019.103390 · DOI · Paper page
- Rhea, 2019, Role of the blood-brain barrier in central nervous system insulin resistance, Front Neurosci, 13, 521, 10.3389/fnins.2019.00521 · DOI · Paper page
- Duffy, 1987, Blood-brain barrier transcytosis of insulin in developing rabbits, Brain Res, 420, 32, 10.1016/0006-8993(87)90236-8 · DOI · Paper page
- Banks, 1998, Differential permeability of the blood-brain barrier to two pancreatic peptides: Insulin and amylin, Peptides, 19, 883, 10.1016/S0196-9781(98)00018-7 · DOI · Paper page
- Gray, 2017, Unravelling the regulation of insulin transport across the brain endothelial cell, Diabetologia, 60, 1512, 10.1007/s00125-017-4285-4 · DOI · Paper page
- Woods, 2003, Insulin and the blood-brain barrier, Curr Pharm Des, 9, 795, 10.2174/1381612033455323 · DOI · Paper page
- Rhea, 2018, Insulin transport across the blood-brain barrier can occur independently of the insulin receptor, J Physiol, 596, 4753, 10.1113/JP276149 · DOI · Paper page
- Hersom, 2018, The insulin receptor is expressed and functional in cultured blood-brain barrier endothelial cells but does not mediate insulin entry from blood to brain, Am J Physiol Endocrinol Metab, 315, E531, 10.1152/ajpendo.00350.2016 · DOI · Paper page
- Gray, 2018, Insulin transport into the brain, Am J Physiol Cell Physiol, 315, C125, 10.1152/ajpcell.00240.2017 · DOI
- Bourassa, 2020, Brain mural cell loss in the parietal cortex in Alzheimer's disease correlates with cognitive decline and TDP-43 pathology, Neuropathol Appl Neurobiol, 46, 458, 10.1111/nan.12599 · DOI
- Bourassa, 2019, Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: Relation with cerebral amyloid angiopathy and Alzheimer's disease, Acta Neuropathol, 137, 801, 10.1007/s00401-019-01967-4 · DOI
- Bennett, 2006, Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study, Neuroepidemiology, 27, 169, 10.1159/000096129 · DOI · Paper page
- Bennett, 2002, Natural history of mild cognitive impairment in older persons, Neurology, 59, 198, 10.1212/WNL.59.2.198 · DOI · Paper page
- Arvanitakis, 2008, Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology, Neurology, 70, 2219, 10.1212/01.wnl.0000313813.48505.86 · DOI · Paper page
- Arvanitakis, 2008, Statins, incident Alzheimer disease, change in cognitive function, and neuropathology, Neurology, 70, 1795, 10.1212/01.wnl.0000288181.00826.63 · DOI · Paper page
- Mirra, 1991, The consortium to establish a registry for Alzheimer's disease (CERAD). part II. Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology, 41, 479, 10.1212/WNL.41.4.479 · DOI · Paper page
- Tremblay, 2017, Association of neuropathological markers in the parietal cortex with antemortem cognitive function in persons with mild cognitive impairment and Alzheimer disease, J Neuropathol Exp Neurol, 76, 70, 10.1093/jnen/nlw109 · DOI
- Tremblay, 2007, Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease, J Alzheimers Dis, 12, 377, 10.3233/JAD-2007-12411 · DOI · Paper page
- Vandal, 2016, Impaired thermoregulation and beneficial effects of thermoneutrality in the 3xTg-AD model of Alzheimer's disease, Neurobiol Aging, 43, 47, 10.1016/j.neurobiolaging.2016.03.024 · DOI
- Vandal, 2015, Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer's disease, FASEB J, 29, 4273, 10.1096/fj.14-268482 · DOI · Paper page
- Do, 2015, Age-dependent regulation of the blood-brain barrier influx/efflux equilibrium of amyloid-beta peptide in a mouse model of Alzheimer's disease (3xTg-AD), J Alzheimers Dis, 49, 287, 10.3233/JAD-150350 · DOI · Paper page
- Stargardt, 2013, Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models, Aging Cell, 12, 499, 10.1111/acel.12074 · DOI · Paper page
- Bosoi, 2021, High-fat diet modulates hepatic amyloid β and cerebrosterol metabolism in the triple transgenic mouse model of Alzheimer's disease, Hepatol Commun, 5, 446, 10.1002/hep4.1609 · DOI
- Barron, 2013, Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: Implications for Alzheimer's disease, PLoS ONE, 8, e78554, 10.1371/journal.pone.0078554 · DOI · Paper page
- Robison, 2020, Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer's disease, J Neuroinflammation, 17, 285, 10.1186/s12974-020-01956-5 · DOI · Paper page
- Chen, 2014, Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Abeta level and microglia activation in the brains of 3xTg-AD mice, Exp Neurol, 261, 610, 10.1016/j.expneurol.2014.06.004 · DOI
- Traversy, 2017, Altered cerebral insulin response in transgenic mice expressing the epsilon-4 allele of the human apolipoprotein E gene, Psychoneuroendocrinology, 77, 203, 10.1016/j.psyneuen.2016.11.028 · DOI · Paper page
- Do, 2014, Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease, Neuropharmacology, 81, 311, 10.1016/j.neuropharm.2014.02.010 · DOI · Paper page
- Escribano, 2009, Beta-cell hyperplasia induced by hepatic insulin resistance: Role of a liver-pancreas endocrine axis through insulin receptor A isoform, Diabetes, 58, 820, 10.2337/db08-0551 · DOI
- Kaminska, 2014, Adipose tissue INSR splicing in humans associates with fasting insulin level and is regulated by weight loss, Diabetologia, 57, 347, 10.1007/s00125-013-3097-4 · DOI
- Besic, 2015, Aberrant liver insulin receptor isoform A expression normalises with remission of type 2 diabetes after gastric bypass surgery, PLoS ONE, 10, e0119270, 10.1371/journal.pone.0119270 · DOI
- Chettouh, 2013, Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors, Cancer Res, 73, 3974, 10.1158/0008-5472.CAN-12-3824 · DOI · Paper page
- Flatt, 1981, Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice, Diabetologia, 20, 573, 10.1007/BF00252768 · DOI · Paper page
- Ahrén, 1997, Regulation of plasma leptin in mice: Influence of age, high-fat diet, and fasting, Am J Physiol, 273, R113
- Williams, 2018, Insulin exits skeletal muscle capillaries by fluid-phase transport, J Clin Invest, 128, 699, 10.1172/JCI94053 · DOI · Paper page
- Meakin, 2018, The beta secretase BACE1 regulates the expression of insulin receptor in the liver, Nat Commun, 9, 1306, 10.1038/s41467-018-03755-2 · DOI · Paper page
- Bao, 2021, Increased beta-site APP cleaving enzyme 1-mediated insulin receptor cleavage in type 2 diabetes mellitus with cognitive impairment, Alzheimers Dement, 17, 1097, 10.1002/alz.12276 · DOI · Paper page
- Baskin, 1983, Regional concentrations of insulin in the rat brain, Endocrinology, 112, 898, 10.1210/endo-112-3-898 · DOI · Paper page
- Cai, 2018, Insulin regulates astrocyte gliotransmission and modulates behavior, J Clin Invest, 128, 2914, 10.1172/JCI99366 · DOI · Paper page
- García-Cáceres, 2016, Astrocytic insulin signaling couples brain glucose uptake with nutrient availability, Cell, 166, 867, 10.1016/j.cell.2016.07.028 · DOI · Paper page
- Schubert, 2004, Role for neuronal insulin resistance in neurodegenerative diseases, Proc Natl Acad Sci USA, 101, 3100, 10.1073/pnas.0308724101 · DOI · Paper page
- Gralle, 2021, Spatial dynamics of the insulin receptor in living neurons, J Neurochem, 156, 88, 10.1111/jnc.14950 · DOI
- Jin, 2011, Insulin reduces neuronal excitability by turning on GABA(A) channels that generate tonic current, PLoS ONE, 6, e16188, 10.1371/journal.pone.0016188 · DOI · Paper page
- Sartorius, 2015, The brain response to peripheral insulin declines with age: A contribution of the blood-brain barrier?, PLoS ONE, 10, e0126804, 10.1371/journal.pone.0126804 · DOI · Paper page
- Hooshmand, 2019, Serum insulin and cognitive performance in older adults: A longitudinal study, Am J Med, 132, 367, 10.1016/j.amjmed.2018.11.013 · DOI
- Li, 2015, Age and its association with low insulin and high amyloid-β peptides in blood, J Alzheimers Dis, 49, 129, 10.3233/JAD-150428 · DOI
- Zhao, 2004, Insulin and the insulin receptor in experimental models of learning and memory, Eur J Pharmacol, 490, 71, 10.1016/j.ejphar.2004.02.045 · DOI · Paper page
- Banks, 1997, Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin, Peptides, 18, 1577, 10.1016/S0196-9781(97)00238-6 · DOI
- Urayama, 2008, Starvation and triglycerides reverse the obesity-induced impairment of insulin transport at the blood-brain barrier, Endocrinology, 149, 3592, 10.1210/en.2008-0008 · DOI · Paper page
- Banks, 2000, Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse, J Gerontol A Biol Sci Med Sci, 55, B601, 10.1093/gerona/55.12.B601 · DOI · Paper page
- Vella, 2018, Insulin receptor isoforms in cancer, Int J Mol Sci, 19, 3615, 10.3390/ijms19113615 · DOI
- Escribano, 2017, The role of insulin receptor isoforms in diabetes and its metabolic and vascular complications, J Diabetes Res, 2017, 1, 10.1155/2017/1403206 · DOI
- Scalia, 2020, Isoform- and paralog-switching in IR-signaling: When diabetes opens the gates to cancer, Biomolecules, 10, 1617, 10.3390/biom10121617 · DOI
- Pandini, 2002, Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved, J Biol Chem, 277, 39684, 10.1074/jbc.M202766200 · DOI · Paper page
- Benyoucef, 2007, Characterization of insulin/IGF hybrid receptors: Contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation, Biochem J, 403, 603, 10.1042/BJ20061709 · DOI · Paper page
- Slaaby, 2006, Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant, J Biol Chem, 281, 25869, 10.1074/jbc.M605189200 · DOI · Paper page
- Arvanitakis, 2021, Brain insulin signaling and cerebrovascular disease in human postmortem brain, Acta Neuropathol Commun, 9, 71, 10.1186/s40478-021-01176-9 · DOI
- Velazquez, 2017, Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease, Neurobiol Aging, 58, 1, 10.1016/j.neurobiolaging.2017.06.003 · DOI · Paper page
- Kappeler, 2008, Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism, PLoS Biol, 6, e254, 10.1371/journal.pbio.0060254 · DOI · Paper page
- Torres-Aleman, 2007, Targeting insulin-like growth factor-1 to treat Alzheimer's disease, Expert Opin Ther Targets, 11, 1535, 10.1517/14728222.11.12.1535 · DOI · Paper page
- Gualco, 2009, IGF-IR in neuroprotection and brain tumors, Front Biosci (Landmark Ed), 14, 352, 10.2741/3249 · DOI
- Rosenzweig, 2020, The continuing evolution of insulin-like growth factor signaling, F1000Res, 9, 205, 10.12688/f1000research.22198.1 · DOI
- Denley, 2005, Molecular interactions of the IGF system, Cytokine Growth Factor Rev, 16, 421, 10.1016/j.cytogfr.2005.04.004 · DOI · Paper page
- Macauley, 2015, Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivo, J Clin Invest, 125, 2463, 10.1172/JCI79742 · DOI · Paper page
- Miners, 2006, Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy, J Neuropathol Exp Neurol, 65, 1012, 10.1097/01.jnen.0000240463.87886.9a · DOI · Paper page
- Farris, 2003, Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo, Proc Natl Acad Sci USA, 100, 4162, 10.1073/pnas.0230450100 · DOI · Paper page
- Kurochkin, 1994, Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme, FEBS Lett, 345, 33, 10.1016/0014-5793(94)00387-4 · DOI · Paper page
- Storck, 2022, The blood-brain barrier in Alzheimer's disease, Handb Exp Pharmacol
- Xie, 2002, Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor, J Neurosci, 22, RC221, 10.1523/JNEUROSCI.22-10-j0001.2002 · DOI · Paper page
- Stockley, 2007, The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain, Biochem Soc Trans, 35, 574, 10.1042/BST0350574 · DOI · Paper page
- Li, 2004, Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients, Proc Natl Acad Sci USA, 101, 3632, 10.1073/pnas.0205689101 · DOI · Paper page
- Fukumoto, 2002, Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease, Arch Neurol, 59, 1381, 10.1001/archneur.59.9.1381 · DOI · Paper page
- Kwart, 2019, A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP β-CTFs, not Aβ, Neuron, 104, 256, 10.1016/j.neuron.2019.07.010 · DOI · Paper page
- Chen, 2018, Reciprocal regulation of eNOS and caveolin-1 functions in endothelial cells, Mol Biol Cell, 29, 1190, 10.1091/mbc.E17-01-0049 · DOI
- Haddad, 2020, Role of caveolin-1 in diabetes and its complications, Oxid Med Cell Longev, 2020, 1, 10.1155/2020/9761539 · DOI
- Taylor, 2003, Curbing activation: Proprotein convertases in homeostasis and pathology, Faseb J, 17, 1215, 10.1096/fj.02-0831rev · DOI · Paper page
- Devraj, 2016, BACE-1 is expressed in the blood-brain barrier endothelium and is upregulated in a murine model of Alzheimer's disease, J Cereb Blood Flow Metab, 36, 1281, 10.1177/0271678X15606463 · DOI · Paper page
- Yuasa, 2016, Sequential cleavage of insulin receptor by calpain 2 and γ-secretase impairs insulin signalling, Diabetologia, 59, 2711, 10.1007/s00125-016-4102-5 · DOI
- Gaborit, 2021, The aminosterol claramine inhibits β-secretase 1-mediated insulin receptor cleavage, J Biol Chem, 297, 100818, 10.1016/j.jbc.2021.100818 · DOI
- Soluble Insulin Receptor Study Group, 2007, Soluble insulin receptor ectodomain is elevated in the plasma of patients with diabetes, Diabetes, 56, 2028, 10.2337/db07-0394 · DOI · Paper page
- Shen, 2018, Increased plasma beta-secretase 1 may predict conversion to Alzheimer's disease dementia in individuals with mild cognitive impairment, Biol Psychiatry, 83, 447, 10.1016/j.biopsych.2017.02.007 · DOI · Paper page
Cited by
Alzheimer’s disease as type 3 diabetes: understanding the link and implications
Kciuk, M., Kruczkowska, W., Gałęziewska, J., Wanke, K., Kałuzińska-Kołat, Ż., Aleksandrowicz, M., & Kontek, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211955 · Cited by 98
“The decreased insulin availability and signaling in the brain can have a profound influence on neuronal function and cognitive processes [21,108,109].”
Rhea, E. M., Babin, A., Thomas, P., Omer, M., Weaver, R., Hansen, K., Banks, W. A., & Talbot, K. (2024) · Tissue Barriers · doi:10.1080/21688370.2023.2292461 · Cited by 81
“As exemplified by insulin and ghrelin, such binding sites can be functional receptors that influence brain endothelial cell functions that are unrelated to the transport of the peptide across the BBB. 69,78,79 The V r of IRAs in the present study was quite variable.”
Insulin Resistance in Peripheral Tissues and the Brain: A Tale of Two Sites
Rhea, E. M., Banks, W. A., & Raber, J. (2022) · Biomedicines · doi:10.3390/biomedicines10071582 · Cited by 76
“IR-B is the predominant form found at the BBB in healthy conditions but there is a shift towards a higher IR-A/B ratio at the BBB in AD that correlates with cognitive score [50].”
BackgroundYan, C., Grabowska, M. E., Dickson, A. L., Li, B., Wen, Z., Roden, D. M., Michael Stein, C., Embí, P. J., Peterson, J. F., Feng, Q., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01038-3 · Cited by 73
State of the science on brain insulin resistance and cognitive decline due to Alzheimer's disease
Rhea, E. M., Leclerc, M., Yassine, H. N., Capuano, A. W., Tong, H., Petyuk, V. A., Macauley, S. L., Fioramonti, X., Carmichael, O., Calon, F., et al. (2023) · Aging and disease · doi:10.14336/ad.2023.0814 · Cited by 70
“Consistently, higher levels of the B isoform are found in cerebrovascular extracts in both mouse and human brains, compared to parenchymal fractions [41].”
BackgroundMethodResultInfluentialSelf-citation
Metadata
- Authors
- Leclerc, M., Bourassa, P., Tremblay, C., Caron, V., Sugère, C., Emond, V., Bennett, D. A., & Calon, F.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-10-25
- Volume
- 146
- Issue
- 1
- Pages
- 75-90
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W4307182538
- Cited by
- 108
- References
- 44
- FWCI
- 11.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- Canadian Institutes of Health Research
- Fonds de recherche du Québec-Santé
- Fondation du CHU de Québe
- Alzheimer Society of Canada
- Fonds d’Enseignement et de la Recherche
- Laval University
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebrovascular insulin receptors are defective in Alzheimer’s disease. https://app.cochat.ai/papers/10.1093/brain/awac309
- The paper
- Leclerc, M., Bourassa, P., Tremblay, C., Caron, V., Sugère, C., Emond, V., Bennett, D. A., & Calon, F. (2023). Cerebrovascular insulin receptors are defective in Alzheimer’s disease. Brain. https://doi.org/10.1093/brain/awac309
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.